nm23 protein expression in renal cell tumors: The role of the cell type

Oncology Reports

Volumn 5, Issue 4, 1998, Pages 979-983

  Ayhan, Ayse ^a   Usubütün, Alp ^a   Özen, Haluk ^a   Yasui, Wataru ^b   Tamara, Eiichi ^b  

^a HACETTEPE UNIVERSITY   (Turkey)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Carcinogenesis; Metastasis suppressor gene; nm23; Renal cell carcinoma

Indexed keywords

ARTICLE; CANCER GRADING; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0031864475     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.4.979     Document Type: Article

References (34)

1. Steeg PS, Bevilacqua G, Kopper L, Thorgiersson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988.
2. Bevilacqua G, Sobel ME, Liotta LA and Steeg PS: Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential. Cancer Res 49: 5185-5190, 1989.
3. Gündüz M, Ayhan A, Güllü I, Önerci M, Hosal AS, Gürsel B, Hosal IN and Firat D: nm23 expression in laryngeal carcinomas. Eur J Cancer 33: 2338-2341, 1997.
4. Saraç E, Ayhan A, Ertoy D, Tuncer S, Yasui W, Tahara E and Ayhan A: Predominance of negative nm23 expression in metastatic lymph nodes and in recurrences in uterine cervix carcinomas. Eur J Gynecol Oncol (In press).
5. Ayhan A, Yasui W, Yokozaki H, Kitadal Y and Tahara E: Reduced expression of nm23 protein is associated with advanced tumor stage and distant metastases in human colorectal carcinomas. Virchows Arch 63: 213-218, 1993.
6. Thrasher B and Paulson D: Prognostic factors in renal cancer. Urol Clin North Am 20: 247-262, 1993.
7. Strohmeyer T and Ackermann R: Classic and modern prognostic indicators in renal cell carcinoma: Review of the literature. Urol Int 47: 203-212, 1991.
8. Takashi M, Nakano Y, Sakata T, Miyake K and Hamajima N: Multivariate evaluation of prognostic determinants for renal cell carcinoma. Urol Int 50: 6-12, 1993.
9. Delabrant B and Nacey JN: Renal cell carcinoma 2. Histological indicators of prognosis. Pathology 19: 258-263, 1987.
10. Stahl JA, Leone A, Rosengard AM, Porter L, King CR and Steeg PS: Identification of a second human nm23 gene, nm23H2. Cancer Res 51: 445-449, 1991.
11. Heide I, Thiede C, Poppe K, Kant E, Huhn D and Rochlitz C. Expression and mutational analysis of nm23-H1 in liver metastases of colorectal cancer. Br J Cancer 70: 1267-1271, 1994.
12. Leone A, McBride OW, Weston A, Wang MG, Anglard P, Cropp CS, Goepel JR, Lidereau R, Callahan R, Linehan WM and Steeg PS: Somatic allelic deletion of nm23 in human cancer. Cancer Res 51: 2490-2493, 1991.
13. Nakayama T, Ohtsuru A, Nakao K, Shima M, Nakata K, Watanabe K, Ishii N, Kimura N and Nagataki S: Expression in human hepatocellular carcinoma of nucleoside diphosphate kinase, a homologue of the nm23 gene product. J Natl Cancer Inst 84: 1349-1354, 1992.
14. Tokunaga Y, Urano T, Furukawa K, Kondo H, Kanematsu T and Shiku H: Reduced expression of nm23-H1, but not of nm23-H2, is concordant with the frequency of lymph-node metastasis of human breast cancer. Int J Cancer 55: 66-71, 1993.
15. Nakayama H, Yasui W, Yokozaki H and Tahara E: Reduced expression of nm23 is associated with metastasis of human gastric carcinomas. Jpn J Cancer Res 84: 184-190, 1993.
16. Yamaguchi A, Urano T, Fushida S, Furukawa K, Nishimura G, Yonemura Y, Miyazaki I, Nakagawara G and Shiku H: Inverse association of nm23-H1 expression by colorectal cancer with liver metastasis. Br J Cancer 68: 1020-1024, 1993.
17. Caligo MA, Grammatico P, Cipollini G, Varesco L, Del Porto G and Bevilacqua G: A low NM23.H1 gene expression identifying high malignancy human melanomas. Melanoma Res 4: 179-184, 1994.
18. Boix L, Bruix J, Campo E, Sole M, Castells A, Fuster J, Rivera F, Cardesa A and Rodes J: Nm23-H1 expression and disease recurrence after surgical resection of small hepatocellular carcinoma. Gastroenterology 107: 486-491, 1994.
19. Royds JA, Cross SS, Silcocks PB, Scholefield JH, Rees RC and Stephenson TJ: Nm23 'anti-metastatic' gene product expression in colorectal carcinoma. J Pathol 172: 261-266, 1994.
20. Yamaguchi A, Urano T, Goi T, Takeuchi K, Niimoto S, Nakagawara G, Furukawa K and Shiku H: Expression of human nm23-H1 and nm23-H2 proteins in hepatocellular carcinoma. Cancer 73: 2280-2284, 1994.
21. Kodera Y, Isobe K, Yamauchi M, Kondoh K, Kimura N, Akiyama S, Itoh K, Nakashima I and Takagi H: Expression of nm23 H-l RNA levels in human gastric cancer tissues. A negative correlation with nodal metastasis. Cancer 73: 259-265, 1994.
22. Xerri L, Grob JJ, Battyani Z, Gouvernet J, Hassoun J and Bonerandi JJ: NM23 expression in metastasis of malignant melanoma is a predictive prognostic parameter correlated with survival. Br J Cancer 70: 1224-1228, 1994.
23. Florenes VA, Aamdal S, Myklebost O, Maelandsmo GM, Bruland OS and Fodstad O: Levels of nm23 messenger RNA in metastatic malignant melanomas: Inverse correlation to disease progression. Cancer Res 52: 6088-6091, 1992.
24. Leone A, Seeger RC, Hong CM, Hu YY, Arboleda MJ, Brodeur GM, Stram D, Slamon DJ and Steeg PS: Evidence for nm23 RNA overexpression, DNA amplification and mutation in aggressive childhood neuroblastomas. Oncogene 8: 855-865, 1993.
25. Higashiyama M, Doi O, Yokouchi H, Kodama K, Nakamori S, Tateishi R and Kimura N: Immunohistochemical analysis of nm23 gene product/NDP kinase expression in pulmonary adenocarcinoma: Lack of prognostic value. Br J Cancer 66: 533-536, 1992.
26. Parley DR, Eberhardt ML, Grant CS, Schaid DJ, van-Heerden JA, Hay ID and Khosla S: Expression of a potential metastasis suppressor gene (nm23) in thyroid neoplasms. World J Surg 17: 615-620, 1993.
27. Luo W, Matsuo K, Nagayama Y, Urano T, Furukawa K, Takeshita A, Nakayama T, Yokoyama N, Yamashita S, Izumi M, et al: Immunohistohemical analysis of expression of nm23-H1/nucleoside diphosphate kinase in human thyroid carcinomas: lack of correlation between its expression and lymph node metastasis. Thyroid 3: 105-109, 1993.
28. Walther MM, Anglard P, Gnarra J, Pozzatti R, Venzon D, Rosa A, MacDonald NJ, Steeg PS and Linehan WM: Expression of nm23 in cell lines derived from patients with metastatic renal cell carcinoma. J Urol 154: 278-282, 1995,
29. Urakami S, Igawa M, Shirakawa H, Shina H and Kawanishi M: Quantitative analysis of nm23 protein immunoreactivity in renal cell carcinoma using an image analyzer. J Urol 157: 1928-1931, 1997.
30. Thoenes W, Störkel S and Rumpel HJ: Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas); The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 181: 125-143, 1986.
31. Peterson RO: Kidney. In: Urologic Pathology. Petersen RO (ed). 2nd edition. J.B. Lippincott Company, Philadelphia, pp69-100, 1992.
32. Nadasdy T, Bane BL and Silva FG: Adult renal diseases. In: Diagnostic Surgical Pathology. Sternberg S (ed). 2nd edition. Raven press, New York, pp1708, 1994.
33. Nakamori S, Ishikawa O, Ohhigashi H, Kameyama M, Furukawa H, Sasaki Y, Inaji H, Higashiyama M, Imaoka S, Iwanaga T, et al: Expression of nucleoside diphosphate kinase/nm23 gene product in human pancreatic cancer: an association with lymph node metastasis and tumor invasion. Clin Exp Metastasis 11: 151-158, 1993.
34. Engel M, Theisinger B, Seib T, Seitz G, Huwer H, Zang KD, Welter C and Dooley S: High levels of nm23-H1 and nm23-H2 messenger RNA in human squamous-cell lung carcinoma are associated with poor differentiation and advanced tumor stages. Int J Cancer 55: 375-379, 1993.